Searched for
DRUG REGULATORY APPROVAL
Japan's Takeda bets on dengue vax to reshape India playbookTakeda Pharmaceutical's new dengue vaccine Qdenga received approval in India. The vaccine is expected to launch commercially in early 2027....- IPA seeks to regularise 'legacy' drugsThe Indian Pharmaceutical Alliance seeks to regularize many drugs. These drugs have been marketed for years without central approval. Examp...
- Government tightens surveillance on GLP-1 weight-loss drug promotion amidst surrogate advertising concernsCentral government directs state regulators to enhance surveillance over GLP-1 drug promotion. Approved GLP-1 drugs are only for Type 2 dia...
- Trump admin pushes tougher English rules for Mexican train crews crossing into USThe Trump administration's latest initiative focuses on improving policies for Mexican train crews by mandating that they grasp key safety ...
- Eric Trump-backed defence technology company Space-Eyes to go public in $638 million SPAC dealSpace-Eyes, a leader in defense technology, has announced its merger with McKinley Acquisition Corp. In a move to enhance strategic oversig...
- Eric Trump-backed defense technology company Space-Eyes to go public in $638 million SPAC deal, sources sayDefense technology company Space-Eyes will merge with McKinley Acquisition Corp. This deal values the combined business at six hundred thir...
- Lupin launches generic Sugammadex injection in USLupin Limited announced the launch of its Sugammadex Injection in the United States. This follows approval from the US Food and Drug Admini...
- India takes action against 90% of inspected high-risk pharmaceutical facilities, regulator saysAmid increasing global concerns over Indian pharmaceuticals, India's drug regulator is rigorously addressing high-risk manufacturing sites....
- Bye-bye painful dentist visit: A simple liquid could stop tooth decay; no drilling or injections needed for many cavitiesA major US clinical trial has found that silver diamine fluoride, a liquid painted onto cavities in seconds, stopped tooth decay in more th...
- Gland Pharma gets USFDA nod for generic sugammadex injectionGland Pharma secured USFDA approval for its sugammadex injection generic version. This drug reverses muscle relaxant effects used during su...
- Centre readies healthcare compliance overhaul to boost hospitals in tier-2, tier-3 citiesIndia plans major healthcare regulatory changes soon. These reforms aim to simplify licensing and reduce compliance burdens. The govt will ...
- Hedge fund bets on rising US healthcare stocks near 5-year high, Goldman saysHedge funds are actively enhancing their stakes in healthcare stocks, reflecting a significant trend in market behavior. With a notable sur...
- US FDA approves world's first oral cholesterol-lowering pill: What it means for patientsThe FDA has approved Lipfendra, an oral PCSK9 inhibitor, for high cholesterol. This new once-daily pill offers an alternative to injectable...
- US tariff proposal wake-up call for Indian pharma to diversify, innovate: ExpertsUS pharma tariffs: Experts have urged a shift towards global diversification and prioritising innovation for Indian pharma to lessen market...
- Organon shareholders approve Sun Pharma's $11.75-bn acquisition proposalSun Pharmaceutical Industries Ltd announced shareholder approval for its Organon & Co acquisition. This significant milestone moves the pro...
- Cipla expects sequential recovery in North America on new product launches despite tariff uncertaintyCipla reported a 39% drop in net profit to ₹789 crore for the June quarter due to weakness in its North America business and margin compres...
- Indian pharma firms may yet survive Trump's 200% tariff bombshellDonald Trump's proposed up to 200% tariff on generic drug imports has raised concerns for Indian pharma companies, but industry experts say...
- Glenmark gets USFDA nod for expanded use of RYALTRIS nasal sprayGlenmark Pharmaceuticals announced US FDA approval for RYALTRIS nasal spray. This approval expands its use to children aged six to twelve y...
- Alembic Pharma partner NATCO gets USFDA tentative nod for generic Olaparib tablets; US market size at USD 1.4 bnAlembic Pharmaceuticals and NATCO Pharma received tentative USFDA approval for generic Olaparib tablets. This approval is for a cancer drug...
- Sun Pharma gets SAHPRA approval for generic semaglutide injection in South Africa for type 2 diabetesSouth Africa's regulator approved Sun Pharma's generic semaglutide injection for diabetes. This approval allows marketing to supplement die...
Load More
